- Trials with a EudraCT protocol (48)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
48 result(s) found for: Adrenal Carcinoma.
Displaying page 1 of 3.
EudraCT Number: 2007-007262-38 | Sponsor Protocol Number: ADIUVO | Start Date*: 2008-03-12 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA S. LUIGI GONZAGA | |||||||||||||
Full Title: Efficacy of adjuvant mitotane treatment in prolonging disease-free survival in patients with adrenocortical cacinoma submitted to radical resection | |||||||||||||
Medical condition: PATIENTS WITH ADRENOCORTICAL CARCINOMA SUBMITTED TO RARICAL SURGERY | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) DE (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001165-15 | Sponsor Protocol Number: SIRAC-1 | Start Date*: 2007-06-08 | |||||||||||
Sponsor Name:University Hospital of Wuerzburg | |||||||||||||
Full Title: Sunitinib in Refractory Adrenocortical-Carcinoma patients progressing after cytotoxic chemotherapy (SIRAC) | |||||||||||||
Medical condition: Adrenocortical Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012820-97 | Sponsor Protocol Number: OSI-906-301 | Start Date*: 2009-12-29 | |||||||||||
Sponsor Name:Astellas Pharma Global Development, Inc. | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of OSI-906 in Patients with Locally Advanced or Metastatic Adrenocortical Carcinoma | |||||||||||||
Medical condition: Adrenocortical Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) FR (Completed) IT (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001802-27 | Sponsor Protocol Number: F002MH0218_1 | Start Date*: 2019-04-16 | ||||||||||||||||||||||||||
Sponsor Name:University Hospital Wuerzburg | ||||||||||||||||||||||||||||
Full Title: A Multicenter, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Cabozantinib in Advanced (Unresectable or Metastatic) Adrenocortical Carcinoma. | ||||||||||||||||||||||||||||
Medical condition: Advanced (Unresectable or Metastatic) Adrenocortical Carcinoma | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000494-91 | Sponsor Protocol Number: PEMBR-01 | Start Date*: 2022-12-22 | |||||||||||
Sponsor Name:Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie, Państwowy Instytut Badawczy | |||||||||||||
Full Title: A multicentre, open-label phase 2 study to evaluate the efficacy and safety of pembrolizumab in the treatment of advanced, progressive adrenocortical carcinoma. | |||||||||||||
Medical condition: carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004137-18 | Sponsor Protocol Number: CO-ACT-001 | Start Date*: 2007-10-19 | |||||||||||
Sponsor Name:Collaborative group for Adrenocortical Carcinoma Therapy (COAT) [...] | |||||||||||||
Full Title: First International Randomized trial in locally advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT) | |||||||||||||
Medical condition: chemotherapy with etoposide, doxorubicin and cisplatin plus mitotane (EDP/M) as first line treatment versus streptozotocin plus mitotane (Sz/M) as first line treatment in advanced and Metastatic Ad... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) NO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004530-38 | Sponsor Protocol Number: ASSTBS-FARONCO-PESETA-20 | Start Date*: 2022-05-30 | |||||||||||
Sponsor Name:AZIENDA SOCIO SANITARIA TERRITORIALE DEGLI SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: PROSPECTIVE, PHASE II STUDY TO EVALUATE THE EFFICACY OF ADDITION OF PROGESTERONE TO STANDARD CHEMOTHERAPY ACCORDING TO EDP SCHEME PLUS MITOTANE IN PATIENTS WITH ADVANCED ADRENALCORTICAL (PESETA TRIAL) | |||||||||||||
Medical condition: advanced/ metastatic patients with ACC | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000945-29 | Sponsor Protocol Number: ASSTBS-ONCO-ABACUS-16 | Start Date*: 2016-06-16 | |||||||||||
Sponsor Name:AZIENDA SOCIO SANITARIA TERRITORIALE DEGLI SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: Activity of Abiraterone Acetate in the management of Cushing’s syndrome in patients with adrenocortical carcinoma (ABACUS) | |||||||||||||
Medical condition: Cushing’s syndrome in patients with adrenocortical carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000580-90 | Sponsor Protocol Number: ASSTBS-ONCO-ACACIA-18 | Start Date*: 2018-06-20 | |||||||||||
Sponsor Name:AZIENDA SOCIO SANITARIA TERRITORIALE DEGLI SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: Multicenter randomized open-label phase III trial of Adjuvant Chemotherapy vs. observation or mitotane after primary surgical resection of localized | |||||||||||||
Medical condition: localized Adrenocortical CarcInomA with high risk of recurrence | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001591-35 | Sponsor Protocol Number: ASST-ONCO-CABAC2017 | Start Date*: 2017-12-27 | |||||||||||
Sponsor Name:AZIENDA SOCIO SANITARIA TERRITORIALE DEGLI SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: Multicenter, prospective, non-randomized, phase II trial designed to evaluate the activity of Cabazitaxel in patients with advanced Adreno-Cortical- Carcinoma progressing after previous chemotherap... | |||||||||||||
Medical condition: Histologically confirmed diagnosis of ACC Locally advanced or metastatic disease not amenable to radical surgery resection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002873-47 | Sponsor Protocol Number: SOGUG2011-03 | Start Date*: 2011-11-25 | |||||||||||
Sponsor Name:Grupo Español de Oncología Genitourinaria (SOGUG) | |||||||||||||
Full Title: PHASE II CLINICAL TRIAL OF DOVITINIB (TKI-258) IN FIRST-LINE METASTATIC OR LOCALLY ADVANCED NON-RESECTABLE ADRENOCORTICAL CARCINOMA | |||||||||||||
Medical condition: Carcinoma adrenocortical metastásico o localmente avanzado no resecable, confirmado histológicamente. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003396-19 | Sponsor Protocol Number: EOADR1-19 | Start Date*: 2020-05-06 | |||||||||||||||||||||
Sponsor Name:Enterome | |||||||||||||||||||||||
Full Title: A phase 1/2 trial of EO2401, a novel microbial-derived peptide therapeutic vaccine, in combination with PD-1 check point blockade, for treatment of patients with locally advanced or metastatic adr... | |||||||||||||||||||||||
Medical condition: - locally advanced or metastatic adrenocortical carcinoma (ACC) - malignant pheochromocytoma/paraganglioma (MPP) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) ES (Ongoing) DE (Ongoing) DK (Ongoing) IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004076-34 | Sponsor Protocol Number: 7487-CL-0209 | Start Date*: 2014-02-27 | ||||||||||||||||||||||||||
Sponsor Name:Astellas Pharma Global Development, Inc. | ||||||||||||||||||||||||||||
Full Title: A phase II open-label rollover study for subjects that have participated in an Astellas sponsored linsitinib trial | ||||||||||||||||||||||||||||
Medical condition: Solid tumors | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: CZ (Completed) PL (Completed) GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-005648-25 | Sponsor Protocol Number: PHRC/07-03/RENNES | Start Date*: 2008-01-31 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:C.H.U. de RENNES | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Carcinome rénal à cellules claires (CRCC) traité par molécules antiangiogéniques en situation adjuvante: valeur pronostique et thérapeutique des altérations du gène VHL et de l’expression plasmatiq... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Carcinome rénal à cellules claires (CRCC) traité par molécules antiangiogéniques en situation adjuvante | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000759-91 | Sponsor Protocol Number: PAXO | Start Date*: 2008-04-24 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA S. LUIGI GONZAGA | ||||||||||||||||||
Full Title: Sorafenib plus paclitaxel metronomic chemotherapy in adreno-cortical-carcinoma patients progressing after 1st or snd line cytotoxic chemotherapy | ||||||||||||||||||
Medical condition: ACC | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004793-26 | Sponsor Protocol Number: TPU-TAS-102-201 | Start Date*: 2013-02-18 | |||||||||||
Sponsor Name:TAIHO PHARMA USA, INC | |||||||||||||
Full Title: AN OPEN-LABEL, RANDOMIZED, PHASE 2 STUDY COMPARING TAS-102 VERSUS TOPOTECAN OR AMRUBICIN IN PATIENTS REQUIRING SECONDLINE CHEMOTHERAPY FOR SMALL CELL LUNG CANCER THAT IS REFRACTORY OR SENSITIVE TO ... | |||||||||||||
Medical condition: Small Cell Lung Cancer that is refractory or sensitive to first-line platinum-based chemotherapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002205-69 | Sponsor Protocol Number: Hepatooma | Start Date*: 2009-08-24 |
Sponsor Name:Organisation name was not entered | ||
Full Title: Investigation of Hepatic Tumors with Positron Emission Tomography Using [11C]-Metomidate and [11C]-Acetate Tracers | ||
Medical condition: This study is planned to determine and compare two new radiotracers (11C-labeled metomidate and acetate) in the detection of malignant and benign hepatic tumors. The detection of hepatocellular car... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002133-37 | Sponsor Protocol Number: COR-2012-01 | Start Date*: 2014-11-17 | |||||||||||
Sponsor Name:Cortendo AB | |||||||||||||
Full Title: An Open Label Study to Assess the Safety and Efficacy of COR—003 (2S, 4R-Ketoconazole) in the Treatment of Endogenous Cushing’s Syndrome | |||||||||||||
Medical condition: Endogenous Cushing's syndrome (CS) or Cushing's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) BE (Completed) NL (Completed) SE (Completed) DK (Completed) DE (Completed) IT (Completed) BG (Completed) CZ (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-003240-30 | Sponsor Protocol Number: CR9304-21 | Start Date*: 2008-12-18 | |||||||||||
Sponsor Name:Cancer Research UK | |||||||||||||
Full Title: A Cancer Research UK Phase I/II Open Label Study to Evaluate the Safety, Endocrine Effects, and Anti-tumour Activity of Abiraterone Acetate (CB7630) in Patients with Oestrogen (ER) or Androgen Rece... | |||||||||||||
Medical condition: Oestrogen (ER) or androgen receptor (AR) positive, advanced or metastatic breast carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014796-51 | Sponsor Protocol Number: 120BC201 | Start Date*: 2010-02-02 | |||||||||||
Sponsor Name:Biogen Idec Ltd. | |||||||||||||
Full Title: Phase 2a, open-label, randomized, noncomparative study of BIIB021 in combination with exemestane in women with hormone receptor-positive, advanced metatatic breast cancer who have progressed on a n... | |||||||||||||
Medical condition: Advanced Metastatic Breast Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.